Shire plc (SHPG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
187.78-2.44 (-1.28%)
As of 12:13 PM EDT. Market open.
People also watch:
JAZZALXNMDVNMNKBMRN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open188.51
Prev Close190.22
Bid187.93 x 300
Ask187.99 x 100
Day's Range187.47 - 188.92
52wk Range147.60 - 231.32
1y Target EstN/A
Market Cap55.93B
P/E Ratio (ttm)39.02
Beta1.54
Volume574,028
Avg Vol (3m)2,034,075
Dividend & Yield0.80 (0.42%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com4 hours ago

    5 Health Care Stocks John Paulson Is Betting On in 2016

    When it comes to investing in health care, hedge fund pro John Paulson knows his stuff.

  • PR Newswire2 days ago

    Shire's First Prescription Eye Drop, Xiidra™ (lifitegrast ophthalmic solution) 5% Is Now Available in the U.S.

    LEXINGTON, Mass., Aug. 29, 2016 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Xiidra™ (lifitegrast ophthalmic solution) 5%, a twice-daily prescription eye drop indicated for the treatment of both the signs and symptoms of dry eye disease, is now available by prescription in the United States. An estimated 16 million adults in the U.S. are diagnosed with dry eye, a disease associated with inflammation that may eventually lead to damage to the surface of the eye. An eye care professional can diagnose dry eye disease based on signs and symptoms and determine management options, which could include the use of a prescription treatment.

  • PR Newswire2 days ago

    Shire's First Prescription Eye Drop, Xiidra™ (lifitegrast ophthalmic solution) 5% is Now Available in the U.S.

    Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Xiidra™ (lifitegrast ophthalmic solution) 5%, a twice-daily prescription eye drop indicated for the treatment of both the signs and symptoms of dry eye disease, is now available by prescription in the United States. An estimated 16 million adults in the U.S. are diagnosed with dry eye, a disease associated with inflammation that may eventually lead to damage to the surface of the eye. An eye care professional can diagnose dry eye disease based on signs and symptoms and determine management options, which could include the use of a prescription treatment.